Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.

Ineligible company

The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.

Financial Relationships

Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit.  Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. 

Conflict of Interest

Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity.  Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation. 

Speaker and Moderator Disclosures

Lee M. Morris, MD, FACS - Nothing to disclose
Lindsay Tse, DO - Nothing to disclose
Iswanto Sucandy, MD, FACS - Nothing to disclose
Jennifer Moffett, MD, FACS - Intuitive: Consultant: Salary
Samuel Guba, MD - Nothing to disclose
Patrick R. Reardon, MD, FACS - Nothing to disclose
Adrian Coleoglou, MD - Nothing to disclose

Video-based Education Committee Disclosures

Adam J. Doyle, MD, FACS  -  Nothing to disclose
Adi Katz, MD, FACS - Nothing to disclose
Andrew S. Wright, MD, FACS - Nothing to disclose
Angela Kokkosis, MD, FACS -  Nothing to disclose
Alisa M. Coker, MD, FACS - Intuitive Surgical: Honorarium: Teacher, Intuitive Surgical: Consultant: Honorarium, Intuitive Surgical: Speaker: Honorarium
Ankit D. Patel, MD, FACS -  Nothing to disclose
Barnard J. Palmer, MD, FACS -  Nothing to disclose
Brian P. Jacob, MD, FACS - International Hernia Collaboration: Equity: Founder, Medtronic: Honorarium/Grant for Meeting: Education
Brian R. Davis, MD, FACS - Nothing to disclose
Christopher Kalmar, MD -   Nothing to disclose
Dana A. Telem, MD, MPH, FACS - Medtronic: Research Funding: Study PI
David J. Rowe, MD, FACS - Nothing to disclose
Flavio G. Rocha, MD, FACS - Medtronic: Honorarium: Teacher, Astra Zeneca: Honorarium: Advisory Board, Oncosil: Honorarium: Consultant
Gustavo G. Fernandez-Ranvier, MD, PhD, FACS -  Nothing to disclose
Imran Hassan, MBBS, FACS - Nothing to disclose
J. Scott Roth, MD, FACS - Becton Dickinson/CR Bard: Honoraria, Grant: Consultant, Investigator, Medtronic: Consulting Honorarium: Consultant, Advanced Medical Solutions: Grant: Research PI
Jacquline M. M. Beitner, MD - Nothing to disclose
John Shuck, MD, FACS - Nothing to disclose
Joseph Scharpf, MD, FACS - Nothing to disclose
Laila Rashidi, MD, FACS - Intuitive Surgical: Honorarium: Teacher
Lee M. Morris, MD, FACS - Nothing to disclose
Leslie A. Deane, MBBS, FRCSC, FACS -  Nothing to disclose
Lindsay Tse, DO -  Nothing to disclose
Manu S. Sancheti, MD, FACS -  Intuitive: Honorarium: Speaker, Surgeon Educator, Mentor
Mark E. Zafereo, MD, FACS - Eli Lilly: Research Grant Funding: PI of Clinical Trial, Merck: Research Grant Funding: PI of Clinical Trial
Matthew M. Smith, MD, FACS - Nothing to disclose
Patrick R. Reardon, MD, FACS -  Nothing to disclose
Paul F. Rider, MD, FACS -  Trevena LLC: Consulting Fee: Consultant
Radu Apostol, DO, FACS -  Nothing to disclose
Rahila Essani, MBBS, FACS - Nothing to disclose
Ramyar Gilani, MD, FACS - Nothing to disclose
Rockson C. Liu, MD, FACS - Intuitive Surgical: Honorarium: Proctor, BARD: Honorarium: Consultant
Rohan A. Joseph, MD, FACS - Nothing to disclose
Roman V. Petrov, MD, FACS - Nothing to disclose
Samir R. Pandya, MD, FACS, FAAP - Nothing to disclose
Sean J. Langenfeld, MD, FACS -   Nothing to disclose
Shamir O. Cawich, MBBS, FACS - Nothing to disclose
Sharon L. Stein, MD, FACS - Nothing to disclose
Sharona B. Ross, MD, FACS - Intuitive Surgical: Honorarium: Consultant and Proctor, Ethicon: Consulting Fees: Consultant, Medtronic: Educational Grant: N/A
Sima P. Porten, MD, FACS - Photocure: Honorarium: Consultant, Stryker: Honorarium: Consultant, Urogen: Honorarium: Advisory Board
Stefan Scholz, MD, FACS - Nothing to disclose
Subhashini M. Ayloo, MD, FACS - Nothing to disclose
Toomas Anton, MD, FACS -  Nothing to disclose